Many of the world's leading causes of irreversible blindness, including glaucoma and age-related macular degeneration, share a common problem: the buildup of fluid, waste and inflammatory debris in the back of the eye.
34 minutes ago
0
0
An NSAID-related compound called ampyrone appears to safely boost production of the pigment melanin in human skin, according to a preclinical study led by Weill Cornell Medicine and National Eye Institute investigators. The ...
4 hours ago
0
0
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...
Jul 17, 2026
0
4
Faculty members at the University of Colorado Anschutz School of Medicine are working together across academic departments to learn more about how menopausal hormone therapy, sometimes referred to as hormone replacement therapy, ...
Jul 17, 2026
0
6
Blinding diseases caused by the degeneration of photoreceptors, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), affect 200 million people worldwide and represent the leading causes of visual ...
Jul 15, 2026
0
141
Often called the silent thief of sight, glaucoma is a group of eye diseases that gradually damage the optic nerve, often without warning signs. It is linked to increased pressure (ocular hypertension) inside the eye and, ...
Researchers at Technion have uncovered a surprising natural mechanism through which the body repairs itself: Contrary to what was previously believed, mature, aged cells retain an extraordinary ability to "turn back time" ...
Jul 14, 2026
0
70
A breakthrough combination of new silicone materials and advanced 3D printing technology developed by University of Waterloo researchers could transform how contact lenses are manufactured. The study, "Patient-specific hard ...
Jul 14, 2026
0
10
Cerebral (or cortical) visual impairment (CVI) is a brain-based visual disorder that is the leading cause of pediatric visual impairment in developed countries. Unfortunately, because of low awareness, CVI is often misdiagnosed ...
Jul 14, 2026
0
3
A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a slightly higher risk of ischemic optic neuropathy (ION), a rare condition involving ...
Jul 13, 2026
0
4
